Results 211 to 220 of about 3,122,352 (307)
CD34 and HLA-DR Double Positive Microgranular Acute Promyelocytic Leukaemia With Multiple T- and B-Cell Markers Expression. [PDF]
Xu K, Vitsaras E, Gupta R.
europepmc +1 more source
A rapid and efficient CRISPR‐mediated gene editing platform for TIL engineering identified FAM84B as a novel potential target to enhance antitumor activity and pioneered the use of CBE to generate FAM84B loss‐of‐function TIL with enhanced antitumor activity.
Fenge Li +13 more
wiley +1 more source
Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failure. [PDF]
Liu X +8 more
europepmc +1 more source
A20 suppresses IFN‐γ signaling in HCC cells by binding to STAT1 through its ZnF7 domain, thereby reducing CXCL9, CXCL10, and HLA‐ABC expression, ultimately impairing CD8+ T‐cell‐mediated anti‐tumor immunity. ABSTRACT Immune checkpoint blockade (ICB) has demonstrated efficacy in clinical cancer therapy; however, a significant proportion of cancer ...
Yanlei Dong +14 more
wiley +1 more source
CD45 on CD33br HLA-DR+ immune cells promote cholecystitis via glycine-mediated pathways: A Mendelian randomization study. [PDF]
Zeng X +7 more
europepmc +1 more source
CAR‐T therapy is evolving across four interconnected dimensions: functional engineering, manufacturing innovation, alternative cell sources, and in vivo CAR programming. Together, these advances address limitations in therapeutic efficacy, safety, manufacturing complexity, scalability, and accessibility, providing complementary paths toward the next ...
Yukimi Sakoda
wiley +1 more source
HLA-DR genotypes in patients with primary Sjögren's syndrome in Taiwan. [PDF]
Yen CY +6 more
europepmc +1 more source
A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells
This study presents a 3D bioprinted platform using gelatin‐hyaluronic acid hydrogels to enhance primary AML cell survival and proliferation while preserving stem‐like properties in vitro. By recapitulating in vivo‐like metabolic activity and drug resistance, this system offers a robust tool for preclinical drug screening and personalised therapy ...
Wanling Huang +10 more
wiley +1 more source

